Pharmacokinetics and Pharmacodynamics of Anacetrapib Following Single Doses in Healthy, Young Japanese and White Male Subjects-Reference-Cited by-同舟云学术

Pharmacokinetics and Pharmacodynamics of Anacetrapib Following Single Doses in Healthy, Young Japanese and White Male Subjects

Published:2017-09-08 Issue:2 Volume:58 Page:254-262
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Krishna Rajesh¹,Gheyas Ferdous¹,Liu Yang¹,Cote Josee¹,Laterza Omar¹,Ruckle Jon L.²³,Wagner John A.¹⁴,Denker Andrew E.¹⁵

Affiliation:

1. MRL; Merck & Co. Inc.; Kenilworth NJ USA

2. Covance Clinical Research Unit; Inc. (formerly known as Radiant Research - Honolulu); Honolulu HI USA

3. Current Address: Pacific Pharma Group, LLC; Tacoma WA USA

4. Current Address: Takeda Pharmaceuticals International Co.; Cambridge MA USA

5. Current Address: Alexion Pharmaceuticals; New Haven CT USA

Funder

Merck

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference26 articles.

1. Plasma cholesteryl ester transfer protein;Tall;J. Lipid Res.,1993

2. Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects;Millar;J Clin Invest,2015

3. Cholesteryl ester transfer protein inhibition with anacetrapib decreases fractional clearance rates of high-density lipoprotein apolipoprotein A-I and plasma cholesteryl ester transfer protein;Reyes-Soffer;Arterioscler Thromb Vasc Biol.,2016

4. Landray MJ Clinical effects of anacetrapib in people with established vascular disease: results of the Randomized EValuation of the Effects of Anacetrapib through Lipid Modification [abstract] European Society of Cardiology Annual Meeting 2017

5. Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib in Japanese patients with dyslipidemia;Teramoto;Atherosclerosis,2013

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics, Safety and Tolerability of Anacetrapib, a Novel Cholesteryl Ester Transfer Protein (CETP) Inhibitor, After Single and Multiple Doses in Healthy Chinese Subjects;Advances in Therapy;2021-06-08

2. The Cholesteryl Ester Transfer Protein Inhibitor, des-Fluoro-Anacetrapib, Prevents Vein Bypass-induced Neointimal Hyperplasia in New Zealand White Rabbits;Scientific Reports;2019-11-07

3. Pharmacokinetics and safety of Enasidenib following single oral doses in Japanese and Caucasian subjects;Pharmacology Research & Perspectives;2018-10-23

4. Pharmacokinetics and Pharmacodynamics of Anacetrapib in Black and White Healthy Subjects;The Journal of Clinical Pharmacology;2018-07-20